Evidence map›Paper›PMID 10531103›Full record

ArticleBMJ (Clinical research ed.)1999

Association between selective serotonin reuptake inhibitors and upper gastrointestinal bleeding: population based case-control study.

F J de Abajo, L A Rodríguez, D Montero

Open access · bronzeAbstract read
In one paragraph

Article in BMJ (Clinical research ed.), 1999. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 115 papers, 9 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
115citing papers in PubMed, 9 pooled it
6.1field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

115 citing papers in PubMed, 9 syntheses or guidelines pooled it, 452 citations in OpenAlex.

  1. Pooled it
  2. Guidelines on optimizing the use of proton pump inhibitors: PPI stewardship.Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology · 2023
    Guideline
  3. Pooled it
  4. Pooled it
  5. Diving and antidepressants.Diving and hyperbaric medicine · 2017
    Guideline
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Validity of diagnostic coding within the General Practice Research Database: a systematic review.The British journal of general practice : the journal of the Royal College of General Practitioners · 2010
    Pooled it
  10. Trial
  11. Trial
  12. Selective serotonin reuptake inhibitors: measurement of effect on platelet function.Translational research : the journal of laboratory and clinical medicine · 2008
    Trial
  13. Trial
  14. Trial
  15. Article
  16. Pharmacotherapy of major depressive disorder in older adults: from an evidence-informed stepwise algorithm to precision medicine.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026
    Review
  17. Article
  18. Article
  19. Article
  20. Article

55 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

F J de AbajoDivisión de Farmacoepidemiología y Farmacovigilancia, Agencia Española del Medicamento, 28220 Majadahonda, Madrid, Spain. fabajo@agemed.es
L A Rodríguez
D Montero
Agencia Española de Medicamentos y Productos Sanitarios · ESCentro Español de Investigación Farmacoepidemiológica · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo examine the association between selective serotonin reuptake inhibitors and risk of upper gastrointestinal bleeding.

designPopulation based case-control study.

settingGeneral practices included in the UK general practice research database. SUBJECTS: 1651 incident cases of upper gastrointestinal bleeding and 248 cases of ulcer perforation among patients aged 40 to 79 years between April 1993 and September 1997, and 10 000 controls matched for age, sex, and year that the case was identified.

interventionsReview of computer profiles for all potential cases, and an internal validation study to confirm the accuracy of the diagnosis on the basis of the computerised information.

main outcome measuresCurrent use of selective serotonin reuptake inhibitors or other antidepressants within 30 days before the index date.

resultsCurrent exposure to selective serotonin reuptake inhibitors was identified in 3.1% (52 of 1651) of patients with upper gastrointestinal bleeding but only 1.0% (95 of 10 000) of controls, giving an adjusted rate ratio of 3.0 (95% confidence interval 2.1 to 4.4). This effect measure was not modified by sex, age, dose, or treatment duration. A crude incidence of 1 case per 8000 prescriptions was estimated. A small association was found with non-selective serotonin reuptake inhibitors (relative risk 1.4, 1.1 to 1.9) but not with antidepressants lacking this inhibitory effect. None of the groups of antidepressants was associated with ulcer perforation. The concurrent use of selective serotonin reuptake inhibitors with non-steroidal anti-inflammatory drugs increased the risk of upper gastrointestinal bleeding beyond the sum of their independent effects (15.6, 6.6 to 36.6). A smaller interaction was also found between selective serotonin reuptake inhibitors and low dose aspirin (7.2, 3.1 to 17.1).

conclusionsSelective serotonin reuptake inhibitors increase the risk of upper gastrointestinal bleeding. The absolute effect is, however, moderate and about equivalent to low dose ibuprofen. The concurrent use of non-steroidal anti-inflammatory drugs or aspirin with selective serotonin reuptake inhibitors greatly increases the risk of upper gastrointestinal bleeding.

Indexed as

AdultAgedAnti-Inflammatory Agents, Non-SteroidalCase-Control StudiesGastrointestinal HemorrhageHumansMiddle AgedRandom AllocationRegression AnalysisRisk FactorsSelective Serotonin Reuptake InhibitorsSex FactorsAnti-Inflammatory Agents, Non-SteroidalSelective Serotonin Reuptake Inhibitors

Identifiers

PMID10531103
PMCPMC28262
OpenAlexW2092902579

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.